Premium
Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa.
Author(s) -
Leeman AL,
O'Neill CJ,
Nicholson PW,
Deshmukh AA,
Denham MJ,
Royston JP,
Dobbs RJ,
Dobbs SM
Publication year - 1987
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1987.tb03223.x
Subject(s) - levodopa , dosing , medicine , morning , placebo , parkinson's disease , insomnia , anesthesia , disease , psychiatry , alternative medicine , pathology
1. Insomnia is an even more frequent complaint in elderly patients with Parkinson's disease than might be expected from the effect of age alone on sleep. 2. A double‐blind, placebo‐controlled trial in eleven patients with Parkinson's disease of mean (s.d.) age 80(5) years, showed that nocturnal dosing with levodopa produced a clinically significant improvement in sleep both as assessed subjectively and by measurement of number of spontaneous moves in bed. 3. Despite the long interval between tablet administration and morning assessment, walking time was faster on mornings following active treatment.